Our findings revealed a marked enrichment of LOXL1 in wound healing and TGF-β dominant subtypes and a downregulated in IFN-γ dominant subtypes in cancers including colorectal (Fig. 7E), suggesting LOXL1’s immunosuppressive role in pan-cancer. This evidence concerns the gene IFNG and cancer.